Trial intelligence / Profile preview

Voriconazole in Chinese subjects with invasive fungal infections

NCT00288197Phase 4Completed

Sponsor
Pfizer
Start
Jan 2006
Primary completion
Jun 2007
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of voriconazole in invasive fungal infection (IFI), sponsored by Pfizer. Started Jan 2006; status: completed.

02

Drugs

voriconazole
03

Conditions

invasive fungal infection (IFI)

Beyond the preview

Go deeper on NCT00288197.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00288197.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call